| Symbol | CRBP |
|---|---|
| Name | CORBUS PHARMACEUTICALS HOLDINGS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 500 RIVER RIDGE DRIVE,SECOND FLOOR, NORWOOD, Massachusetts, 02062, United States |
| Telephone | +1 617 963-0100 |
| Fax | — |
| — | |
| Website | https://www.corbuspharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001595097 |
| Description | Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The companys lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Additional info from NASDAQ: |
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
Read more(90% Positive) CORBUS PHARMACEUTICALS HOLDINGS, INC. (CRBP) Provides Update on evolution for quick succession
Read moreCorbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
Read moreCorbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer
Read moreNew Form S-8 - Corbus Pharmaceuticals Holdings, Inc. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 0001193125-26-274226 <b>Size:</b> 742 KB
Read moreKung Winston 🔴 sold 2.0K shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) at $7.91 Transaction Date: Jun 10, 2026 | Filing ID: 267672
Read moreAltmeyer Anne 🔴 sold 2.4K shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) at $7.91 Transaction Date: Jun 10, 2026 | Filing ID: 267655
Read moreJenkins John Kenneth 🔴 sold 4.8K shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) at $7.91 Transaction Date: Jun 10, 2026 | Filing ID: 267671
Read moreSaxena Nishant C 🟢 acquired 13.5K shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) at $7.58 Transaction Date: Jun 02, 2026 | Filing ID: 255834
Read moreNew Form S-8 - Corbus Pharmaceuticals Holdings, Inc. <b>Filed:</b> 2026-05-29 <b>AccNo:</b> 0001193125-26-248550 <b>Size:</b> 337 KB
Read more